随着人口老龄化日趋严重,骨质疏松症已成为我们面临的主要公共健康问题。骨质疏松症是一种导致骨折风险升高的疾病,其主要表现为患者的骨密度降低,骨微结构恶化,骨骼内蛋白质的数量和种类发生变化。可发生于任何年龄,但多见于绝经后女性和老年男性。2025年10月30日,据中国国家药品监督管理局(NMPA)官网最新公示,山东新华制药股份有限公司按化药注册分类3类申报的阿仑膦酸钠口服溶液获批上市,视同过评。公开...
Source Link随着人口老龄化日趋严重,骨质疏松症已成为我们面临的主要公共健康问题。骨质疏松症是一种导致骨折风险升高的疾病,其主要表现为患者的骨密度降低,骨微结构恶化,骨骼内蛋白质的数量和种类发生变化。可发生于任何年龄,但多见于绝经后女性和老年男性。2025年10月30日,据中国国家药品监督管理局(NMPA)官网最新公示,山东新华制药股份有限公司按化药注册分类3类申报的阿仑膦酸钠口服溶液获批上市,视同过评。公开...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.